Results
|
1.
|
|
|
2.
|
Ultrathin Bioresorbable-Polymer Sirolimus-Eluting Stents Versus Thin Durable-Polymer Everolimus-Eluting Stents for Coronary Revascularization: 3-Year Outcomes From the Randomized BIOFLOW V Trial. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2020
Citation: - Jacc: Cardiovascular Interventions. 13(11):1343-1353, 2020 06 08.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, BIOFLOW V Investigators, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Roguin A, Waksman R
|
|
3.
|
Subgroup Analysis Comparing Ultrathin, Bioresorbable Polymer Sirolimus-Eluting Stents Versus Thin, Durable Polymer Everolimus-Eluting Stents in Acute Coronary Syndrome Patients. MedStar authors:
- Garcia-Garcia, Hector M
- Waksman, Ron
Year: 2018
Citation: - Circulation: Cardiovascular Interventions. 11(10):e007331, 2018 Oct.
Institution: - MedStar Heart & Vascular Institute
Medline publication type:
All authors: - Bennett J, Cutlip DE, Doros G, Garcia-Garcia HM, Gharib EG, Kandzari DE, Koolen JJ, Marcusohn E, Massaro JM, Roguin A, Waksman R
|
|
4.
|
Small-vessel PCI outcomes in men, women, and minorities following platinum chromium everolimus-eluting stents: Insights from the pooled PLATINUM Diversity and PROMUS Element Plus Post-Approval studies. MedStar authors:
Year: 2019
Citation: - Catheterization & Cardiovascular Interventions. 94(1):82-90, 2019 Jul 01.
Institution: - MedStar Union Memorial Hospital
Medline publication type:
All authors: - Allocco D, Aquino M, Batchelor W, Claessen BE, Davis S, Gigliotti OS, Giugliano G, Guedeney P, Haghighat A, Horwitz PA, Kandzari DE, Lopez M, Mehran R, Meredith IT, Othman I, Singh S, Sorrentino S, Tamis L, Underwood P, Wang JC
|